Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Cardiome Pharma Corp    COM   CA14159U3010

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Engages in the discovery, development and commercialization of new therapies

Cardiome Pharma Corp. is a pharmaceutical company engages in provision of development and commercialization of medical products.

It focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease.

It offers the Brinavess and Aggrastat products to customers such as physicians, patients, and healthcare systems.

The company was founded on December 12, 1986 and is headquartered in Vancouver, Canada.


Sales per Businesses
20152016Delta
CAD (in Million)%CAD (in Million)%
Cardiovascular Therapies26.75100%33.46100% +25.08%
Sales per Regions
20152016Delta
CAD (in Million)%CAD (in Million)%
Europe13.5350.6%14.4843.3% +7.08%
Rest of World13.2349.4%18.9856.7% +43.5%
Managers
NameAgeSinceTitle
William L. Hunter, MD532007President, Chief Executive Officer & Director
William James O'Shea672014Chairman
Sheila M. Grant, MBA-2003Chief Operating Officer
Justin A. Renz MBA, CPA452017Chief Financial Officer
Richard M. Glickman, PhD592006Lead Independent Director
Mark H. N. Corrigan, MD592015Director
Arthur H. Willms772015Independent Director
Robert James Meyer, MD-2015Director
Jennifer Archibald-2006Chief Business Operations Officer
Steen Juul-Möller MD, PhD-2013Medical Director-Europe
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 33,801,015 32,947,791 97.5% 0 0.0% 97.5%
Shareholders
NameEquities%
Westfield Capital Management Co. LP 4,931,969 15.5%
Putnam Investment Management LLC 3,924,346 12.3%
Stonepine Capital Management LLC 3,158,816 9.91%
Clough Capital Partners LP 2,878,985 9.03%
Tamarack Advisers LP 1,825,000 5.73%
Rock Springs Capital Management LP 1,200,000 3.76%
William L. Hunter, MD 814,304 2.55%
AlphaOne Investment Services LLC 632,739 1.99%
Renaissance Technologies LLC 350,713 1.10%
JPMorgan Securities LLC (Investment Management) 155,095 0.49%
Company contact information
Cardiome Pharma Corp.
1441 Creekside Drive
6th Floor
Vancouver, BC V6J 4S7

Phone : +1.604.677.6905
Fax : +1.604.677.6915
Web : www.cardiome.com
Sector Biopharmaceuticals
1st jan.Capitalization (M$)
CARDIOME PHARMA CORP-32.32%74
BIOGEN20.55%67 447
CSL LIMITED33.20%48 470
ALEXION PHARMACEUTICALS16.81%31 898
GRIFOLS SA24.55%17 183
BIOMARIN PHARMACEUTICAL11.75%16 225
CHONGQING ZHIFEI BIOLOGICAL PRDCT CO LTD--.--%6 193
3SBIO INC63.16%4 146
ABCAM PLC33.77%2 823
BOYA BIO-PHARMACEUTICAL GROUP CO LTD--.--%2 248
HUGEL INC--.--%2 063
BIOTEST AG76.10%1 195
PHARMA MAR SA27.12%906
PROMETIC LIFE SCIENCES INC.-31.58%847
ANIKA THERAPEUTICS INC16.46%836
SYROS PHARMACEUTICALS INC27.14%423
CHEMOCENTRYX INC-1.49%355
WILSON THERAPEUTICS AB51.40%260
SYNDAX PHARMACEUTICALS INC63.04%260
STRONGBRIDGE BIOPHARMA PLC204.17%258
KADMON HOLDINGS INC-35.89%178
Connections : Cardiome Pharma Corp
Nabriva Therapeutics AG
Kyowa Kirin International Plc
Zalicus Pharmaceuticals Ltd.
Trevi Therapeutics, Inc.
Quartet Medicine, Inc.
Premier's Technology Council
Virginia Center For Translational & Regulatory Sciences
Brighton Biotech, Inc.
Richardson Capital Ltd.
Michael Smith Foundation for Health Research
The Vancouver Symphony Foundation
Synereca Pharmaceuticals, Inc.
Advanced Applied Physics Solutions, Inc.
Pamlico BioPharma, Inc.
enGene, Inc.
Vancouver Symphony Orchestra
MedGenesis Therapeutix, Inc.
British Columbia Lottery Corp.
Vida Pharmaceuticals Pvt Ltd.
The 2010 Games Operating Trust
Kearny Venture Partners
Pacific Autism Family Centre Foundation
Blackthorn Therapeutics, Inc.
Correvio International SARL
© 2017 People , Fundamentals and Ownership